Home/Filings/4/0001178913-18-001605
4//SEC Filing

Bright Rex 4

Accession 0001178913-18-001605

CIK 0001606645other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 5:38 PM ET

Size

5.8 KB

Accession

0001178913-18-001605

Insider Transaction Report

Form 4
Period: 2018-05-08
Bright Rex
Director
Transactions
  • Award

    Options

    2018-05-08+24,94724,947 total(indirect: See footnote)
    Exercise: $5.06Exp: 2028-05-08Ordinary Shares (24,947 underlying)
Footnotes (3)
  • [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
  • [F2]The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 8, 2019.
  • [F3]The options are held by the Bright Family Trust whose trustees are Rex and Marilyn Bright.

Issuer

Foamix Pharmaceuticals Ltd.

CIK 0001606645

Entity typeother

Related Parties

1
  • filerCIK 0001327501

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:38 PM ET
Size
5.8 KB